96 related articles for article (PubMed ID: 37897262)
21. Comprehensive Analysis of Disulfidptosis-Related LncRNAs in Molecular Classification, Immune Microenvironment Characterization and Prognosis of Gastric Cancer.
Kang K; Li X; Peng Y; Zhou Y
Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137387
[TBL] [Abstract][Full Text] [Related]
22. A Model to Predict Prognosis of Renal Cell Clear Cell Carcinoma Based on 3 Angiogenesis-related Long Non-coding RNAs.
Chen G; Zhang T; Li F; Cui C; Huang Z; Gou X; Song Y; Li Y
J Cancer; 2024; 15(11):3481-3494. PubMed ID: 38817877
[No Abstract] [Full Text] [Related]
23. A promising natural killer cell-based model and a nomogram for the prognostic prediction of clear-cell renal cell carcinoma.
Yao Q; Zhang X; Wang Y; Wang C; Chen J; Chen D
Eur J Med Res; 2024 Jan; 29(1):73. PubMed ID: 38268058
[TBL] [Abstract][Full Text] [Related]
24. Single-cell disulfidptosis regulator patterns guide intercellular communication of tumor microenvironment that contribute to kidney renal clear cell carcinoma progression and immunotherapy.
Xu K; Li D; Qian J; Zhang Y; Zhang M; Zhou H; Hou X; Jiang J; Zhang Z; Sun H; Shi G; Dai H; Liu H
Front Immunol; 2024; 15():1288240. PubMed ID: 38292868
[TBL] [Abstract][Full Text] [Related]
25. Fatty acid metabolism-related lncRNAs are potential biomarkers for survival prediction in clear cell renal cell carcinoma.
Zhang MQ; Yang BZ; Wang ZQ; Guo S
Medicine (Baltimore); 2024 Feb; 103(8):e37207. PubMed ID: 38394500
[TBL] [Abstract][Full Text] [Related]
26. Preliminary findings on the development of a predictive model for BLCA based on disulfidptosis-associated IncRNAs signature.
Tang C; Fan Y; Zhu S
BMC Urol; 2024 Mar; 24(1):69. PubMed ID: 38532369
[TBL] [Abstract][Full Text] [Related]
27. Predicting colorectal cancer prognosis based on long noncoding RNAs of disulfidptosis genes.
Wang KL; Chen KD; Tang WW; Chen ZP; Wang YJ; Shi GP; Chen YG
World J Clin Oncol; 2024 Jan; 15(1):89-114. PubMed ID: 38292658
[TBL] [Abstract][Full Text] [Related]
28. Machine learning-based disulfidptosis-related lncRNA signature predicts prognosis, immune infiltration and drug sensitivity in hepatocellular carcinoma.
Pu L; Sun Y; Pu C; Zhang X; Wang D; Liu X; Guo P; Wang B; Xue L; Sun P
Sci Rep; 2024 Feb; 14(1):4354. PubMed ID: 38388539
[TBL] [Abstract][Full Text] [Related]
29. Validation and identification of anoikis-related lncRNA signatures for improving prognosis in clear cell renal cell carcinoma.
Zhu Z; Wang Q; Zeng X; Zhu S; Chen J
Aging (Albany NY); 2024 Feb; 16(4):3915-3933. PubMed ID: 38385949
[TBL] [Abstract][Full Text] [Related]
30. Disulfidptosis features and prognosis in head and neck squamous cell carcinoma patients: unveiling and validating the prognostic signature across cohorts.
Xue H; Sun Q; Zhang H; Huang H; Xue H
J Cancer Res Clin Oncol; 2024 Mar; 150(3):156. PubMed ID: 38526631
[TBL] [Abstract][Full Text] [Related]
31. Development of a prognostic model based on different disulfidptosis related genes typing for kidney renal clear cell carcinoma.
Feng Y; Wang W; Jiang S; Liu Y; Wang Y; Zhan X; Zhu H; Du G
Front Pharmacol; 2024; 15():1343819. PubMed ID: 38549669
[No Abstract] [Full Text] [Related]
32. Construction of a novel disulfidptosis-related lncRNAs signature for prognosis prediction and anti-tumor immunity in laryngeal squamous cell carcinoma.
Zhang M; Sun Q; Han Z; Qin X; Gao T; Xu Y; Han S; Zhang Y; Liang Q; Guo Z; Liu J
Heliyon; 2024 May; 10(10):e30877. PubMed ID: 38774325
[TBL] [Abstract][Full Text] [Related]
33.
Sun XY; Xiao M; Fu M; Gao Q; Li RF; Wang J; Li SL; Ge XY
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540687
[TBL] [Abstract][Full Text] [Related]
34. Signature Construction and Disulfidptosis-Related Molecular Cluster Identification for Better Prediction of Prognosis in Glioma.
Zhuang Y; Chen J; Mai Z; Huang W; Zhong W
J Mol Neurosci; 2024 Apr; 74(2):38. PubMed ID: 38573391
[TBL] [Abstract][Full Text] [Related]
35. Unlocking the future of hepatocellular carcinoma treatment: A comprehensive analysis of disulfidptosis-related lncRNAs for prognosis and drug screening.
Wang H; Wang W
Open Med (Wars); 2024; 19(1):20240919. PubMed ID: 38584823
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of disulfidptosis-related lncRNAs for predicting prognosis and response of immunotherapy in pancreatic adenocarcinoma.
Guo J; Wang Y; Hou J; Zhao T; Wei Z
Transl Cancer Res; 2024 Mar; 13(3):1336-1350. PubMed ID: 38617527
[TBL] [Abstract][Full Text] [Related]
37. Effects of Purine Metabolism-Related
Yin W; Wang JH; Liang YM; Liu KH; Chen Y; Chen YS
Front Biosci (Landmark Ed); 2023 Dec; 28(12):354. PubMed ID: 38179759
[TBL] [Abstract][Full Text] [Related]
38. Identification of cuproptosis-related lncRNAs signature for predicting the prognosis in patients with kidney renal clear cell carcinoma.
He Y; Zhang H; Li J; Zhou H; Wang F; Zhang G; Wen Y
J Genet Eng Biotechnol; 2024 Mar; 22(1):100338. PubMed ID: 38494257
[TBL] [Abstract][Full Text] [Related]
39. Identification of a disulfidptosis-related lncRNA signature for the prognostic and immune landscape prediction in head and neck squamous cell carcinoma.
Wei Z; Zhou C; Fang Y; Deng H; Shen Z
Discov Oncol; 2024 Mar; 15(1):75. PubMed ID: 38483698
[TBL] [Abstract][Full Text] [Related]
40. Integrated analysis of disulfidptosis-related immune genes signature to boost the efficacy of prognostic prediction in gastric cancer.
Li J; Yu T; Sun J; Ma M; Zheng Z; He Y; Kang W; Ye X
Cancer Cell Int; 2024 Mar; 24(1):112. PubMed ID: 38528532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
